1-5 of 5
Loren Joseph
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer

Free
Reba Mustafi, Urszula Dougherty, Devkumar Mustafi, Fatma Ayaloglu-Butun, Michelle Fletcher, Sarbani Adhikari, Farhana Sadiq, Katherine Meckel, Haider I. Haider, Abdurahman Khalil, Joel Pekow, Vani Konda, Loren Joseph, John Hart, Alessandro Fichera, Yan Chun Li, Marc Bissonnette
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 549–561.
https://doi.org/10.1158/1078-0432.CCR-15-3140
Published: 15 January 2017
View articletitled, ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer
Open the PDF for ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer in another window
Includes: Supplementary data
Journal Articles

The Renin–Angiotensin System Mediates EGF Receptor–Vitamin D Receptor Cross-Talk in Colitis-Associated Colon Cancer

Free
Urszula Dougherty, Reba Mustafi, Farhana Sadiq, Anas Almoghrabi, Devkumar Mustafi, Maggi Kreisheh, Sumana Sundaramurthy, Weicheng Liu, Vani J. Konda, Joel Pekow, Sharad Khare, John Hart, Loren Joseph, Alice Wyrwicz, Gregory S. Karczmar, Yan Chun Li, Marc Bissonnette
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (22): 5848–5859.
https://doi.org/10.1158/1078-0432.CCR-14-0209
Published: 13 November 2014
View articletitled, The Renin–Angiotensin System Mediates EGF Receptor–Vitamin D Receptor Cross-Talk in Colitis-Associated Colon Cancer
Open the PDF for The Renin–Angiotensin System Mediates EGF Receptor–Vitamin D Receptor Cross-Talk in Colitis-Associated Colon Cancer in another window
Includes: Supplementary data
Journal Articles

Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial

Free
Nitin Jain, Emily Curran, Neil M. Iyengar, Ernesto Diaz-Flores, Rangesh Kunnavakkam, Leslie Popplewell, Mark H. Kirschbaum, Theodore Karrison, Harry P. Erba, Margaret Green, Xavier Poire, Greg Koval, Kevin Shannon, Poluru L. Reddy, Loren Joseph, Ehab L. Atallah, Philip Dy, Sachdev P. Thomas, Scott E. Smith, L. Austin Doyle, Walter M. Stadler, Richard A. Larson, Wendy Stock, Olatoyosi Odenike
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2): 490–498.
https://doi.org/10.1158/1078-0432.CCR-13-1311
Published: 16 January 2014
View articletitled, Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial
Open the PDF for Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial in another window
Includes: Supplementary data
Journal Articles

Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2

Free
Urszula Dougherty, Dario Cerasi, Ieva Taylor, Masha Kocherginsky, Ummuhan Tekin, Shamiram Badal, Lata Aluri, Amikar Sehdev, Sonia Cerda, Reba Mustafi, Jorge Delgado, Loren Joseph, Hongyan Zhu, John Hart, David Threadgill, Alessandro Fichera, Marc Bissonnette
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 6780–6789.
https://doi.org/10.1158/1078-0432.CCR-09-1678
Published: 11 November 2009
View articletitled, Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2
Open the PDF for Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2 in another window
Includes: Supplementary data
Journal Articles

Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model

Free
Urszula Dougherty, Amikar Sehdev, Sonia Cerda, Reba Mustafi, Nathaniel Little, Weihua Yuan, Sujatha Jagadeeswaran, Anusara Chumsangsri, Jorge Delgado, Maria Tretiakova, Loren Joseph, John Hart, Ezra E.W. Cohen, Lata Aluri, Alessandro Fichera, Marc Bissonnette
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (8): 2253–2262.
https://doi.org/10.1158/1078-0432.CCR-07-4926
Published: 15 April 2008
View articletitled, Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model
Open the PDF for Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model in another window
Includes: Supplementary data